FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Lupin Somerset Gavilyte-N Recall

Gavilyte-N, PEG-3350, Sodium chloride, Sodium Bicarbonate and Potassium Chloride for Or…

LUPIN SOMERSET · Somerset, NJ

Risk level
Class II
Reported by FDA
Apr 17, 2019
Recall ID
D-1113-2019
Check your lot numberHow we source this data

Summary

Lupin Somerset recalled Gavilyte-N starting Mar 19, 2019. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1113-2019 on Apr 17, 2019. Reason: Labeling Not Elsewhere Classified; orange and cherry flavor packets incorrect list "natural lemon flavor" as an ingredient. Status: Terminated.

Why it was recalled

Labeling Not Elsewhere Classified; orange and cherry flavor packets incorrect list "natural lemon flavor" as an ingredient

Product description

Gavilyte-N, PEG-3350, Sodium chloride, Sodium Bicarbonate and Potassium Chloride for Oral Solution, Rx only, Manufactured by Novel Laboratories, Inc. Somerset, NJ 08873 Manufactured for Lupin Pharmaceuticals, Inc. Baltimore, MD NDC 43386-050-19 UPC 343386050192 a) Lemon Flavor Pack net wt. 2 g UPC 343386200023 b) Orange Flavor Pack net wt. 2 g UPC 343386202027 c) Cherry Flavor Pack net wt. 2 g UPC 3433862034

Lot numbers, UPCs & expiration codes

Lot #: a) S800021, Exp 30-Nov-20; b) S800175, Exp 31-Dec-20; c) S 800401, Exp 28-Feb-21; S800426, Exp 31-Mar-21; S800920, Exp 31-Aug-21.

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1113-2019
Classification
Class II
Status
Terminated
Recall initiated
Mar 19, 2019
FDA report date
Apr 17, 2019
Quantity
76422 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
LUPIN SOMERSET

Original FDA data

Every field from FDA enforcement report D-1113-2019, exactly as published.

Show all FDA fields
City
Somerset
State
NJ
Status
Terminated
Country
United States
Event ID
82396
Address
400 Campus Dr
Code information
Lot #: a) S800021, Exp 30-Nov-20; b) S800175, Exp 31-Dec-20; c) S 800401, Exp 28-Feb-21; S800426, Exp 31-Mar-21; S800920, Exp 31-Aug-21.
Postal code
08873-1145
Report date
Apr 17, 2019
Product type
Drugs
Recall number
D-1113-2019
Classification
Class II
Recalling firm
LUPIN SOMERSET
Product quantity
76422 bottles
Termination date
May 23, 2022
Reason for recall
Labeling Not Elsewhere Classified; orange and cherry flavor packets incorrect list "natural lemon flavor" as an ingredient
Voluntary / mandated
Voluntary: Firm initiated
Product description
Gavilyte-N, PEG-3350, Sodium chloride, Sodium Bicarbonate and Potassium Chloride for Oral Solution, Rx only, Manufactured by Novel Laboratories, Inc. Somerset, NJ 08873 Manufactured for Lupin Pharmaceuticals, Inc. Baltimore, MD NDC 43386-050-19 UPC 343386050192 a) Lemon Flavor Pack net wt. 2 g UPC 343386200023 b) Orange Flavor Pack net wt. 2 g UPC 343386202027 c) Cherry Flavor Pack net wt. 2 g UPC 3433862034
Distribution pattern
Nationwide
Recall initiation date
Mar 19, 2019
Initial firm notification
Letter
Center classification date
Apr 9, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1113-2019, published Apr 17, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls